QuantumScape Corporation (NYSE: QS) recently achieved a significant manufacturing milestone, leading to a 35% surge in its stock during after-hours trading. The solid-state battery developer ...

Businesses say the rising music licensing costs have become overwhelming, and some question whether it’s even worth playing ...

Businesses say the rising licensing costs have become overwhelming, and some question whether it’s even worth playing music at all.

Read the Market Summary Here @- Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated Global Automotive Timing Chain and Belt Market size by value at ...

On July 2, 2025, the U.S. Department of Justice (DOJ) and the Department of Health and Human Services (HHS) jointly announced the reestablishment ...

The vacuum blood collection tube market experiences transformative growth driven by chronic disease management requirements, technological innovation ...

Rémy faces ESG risks, arising from the dependence on the Cognac region for production. Climate change poses a long-term threat to the viability of the Ugni Blanc, the primary grape variety distilled ...

Automated test equipment market is pivoting from speed-centric instruments toward cloud-anchored, AI-driven, mixed-signal platforms that handle 6G, E ...

Introduction to Pet Business Insurance 2. Understanding Global Risk Factors 3. Types of Insurance Coverage for Pet Businesses 4. Legal and Regulatory Considerations 5. Case Studies of International ...

Wrangler has signed a multiyear licensing agreement for Genesco to start designing and marketing the denim brand's footwear. Genesco and Kontoor Brands, which owns Wrangler, said Tuesday that the ...

GREENSBORO, N.C. — July15, 2025 — Wrangler and Genesco — a footwear industry leader with a portfolio of owned and licensed lifestyle brands and more than 1,250 retail stores — have signed a new ...

-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...